EVALUATION OF MODERN PROPHYLACTIC FEATURES IN RETINAL DEGENERATIVE PATHOLOGIES OF THE EYE
Keywords:
age-related macular degeneration (AMD), primary open-angle glaucoma (POAG), vitamins, antioxidants, partially oxidized free radicals, Ophthalmocomplex drug, healthy eatingAbstract
Age-related macular degeneration (AMD) is a progressive eye disease in which the physiological function of the choriocapillaries, Bruch’s membrane, and retinal pigment epithelium (RPE) are impaired, a defect in the photoreceptor layer occurs, and central vision is irreversible. Primary open-angle glaucoma (POAG) is a pathological process characterized by impaired hydrodynamics of intraocular fluid and damage to the optic nerve, although the anterior chamber angle is open. In this disease, intraocular pressure (IOP) often increases and peripheral vision decreases depending on the retinal layer's level of compression. According to WHO statistics, POAG is then complicated by the “dry” form of AMD in 41% of cases, i.e. an effective combination of the above two pathologies can be observed in clinical practice. Consumption of foods rich in antioxidant micronutrients and drugs likes “Ophthalmocomplex” in the prevention and treatment of chronic degenerative eye diseases such as primary open-angle glaucoma (POAG) and age-related macular degeneration (AMD) can shorten the rehabilitation period. The mechanisms of development of pathological processes (especially inflammation, degeneration) are different. Still, the main pathogenetic point is the disruption of the antioxidant defense system as a result of detoxification.
References
Kiselyova TN, Polunin GS, Budzinskaya MV, Lagutina YM, Vorobyova MV. Modern approaches to the treatment and prevention of yellow spot degeneration. Jurn. [Russian medical journal] 2007; 2: 78–79. (in Russia).
Seddon J. M., Ajani U. A., Sperduto R. D. Dietary carotenoids, vitamin A, C and E and advanced age-related macular degeneration: Eye Disease case-Control Study Group. JAVA 1994; 272: 1413 1420.
Evans Jr. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration// Cochrane Database Syst. Rev. 2006;19 (2): 54.
Lyle B. J., Mares-Perlman J. A., Klein B. E. et al. Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am. J. Epidemiol. 1999;149 (39): 801 809.
Zeimer M., Hense H. W., Heimes B. et al. The macular pigment: short- and intermediate - term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co - antioxidants. The LUNA Study / Ophthalmologe 2009;106:29 36.
Blokhina O., Virolainen E., Fagerstedt K. V. Antioxidants, Oxidative Damage and Oxygen Deprivation Stress: a Review. Annals of Botany 2003; 91: 179 194.
Kim S. R., Nakanishi K., Itagaki Y. et al. Photooxidation of A2 PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp. Eye Res. 2006; 82 (5): 828 39.
Bressler N. M., Silva J. C., Bressler S. B. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina 2005; 25:130 42.
The Age- Related Eye Disease Study Research Group. A randomized, placebocontrolled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss.
Beatty S., Koh H-H. Henson D., Bouston M. et al. Role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 2000;45:115 134.
